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Abstract – The authors presented the symptoms of multiple scle-
rosis. They pointed out that the disease, which gives extensive 
damage to the myelin sheath around the protrusions of nerve 
cells, causes an impaired transmission of impulses along the 
nerve pathways in the brain and spinal cord at various levels, 
which can lead to a very different picture of the disease. The dis-
ease may develop acutely or subacutely. It is most often multi-
phase with periods of exacerbation and remission. Patients with 
multiple sclerosis are also subject to mental disorders. The pro-
gress of the disease also contributes to the increase in patient's 
disability. The authors also discussed the diagnostics of multiple 
sclerosis, stressing that its initiation in the early phase of the dis-
ease may affect the extension of the duration of the period, which 
is characterized by a reduced number of symptoms. 
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Streszczenie – Autorzy przedstawili objawy stwardnienia rozsia-
nego. Zwrócili uwagę, że choroba dając wielomiejscowe uszko-
dzenia otoczki mielinowej wokół wypustek komórek nerwowych, 
powoduje na różnych poziomach upośledzenie prawidłowego 
przekazywania impulsów wzdłuż dróg nerwowych w mózgowiu i 
rdzeniu kręgowym, co w konsekwencji może prowadzić do bar-
dzo zróżnicowanego obrazu choroby. Choroba może rozwijać się 
ostro lub podostro. Najczęściej ma charakter wielofazowy z okre-
sami zaostrzeń i remisji. Chorzy ze stwardnieniem rozsianym 
podlegają także zaburzeniom psychicznym. Postęp choroby przy-
czynia się również do narastania niepełnosprawności chorego. 
Autorzy omówili ponadto diagnostykę stwardnienia rozsianego, 
podkreślając, że rozpoczęcie jej we wczesnej fazie choroby może 
wpłynąć na wydłużenie trwania okresu, który charakteryzuje się 
zmniejszoną liczbą objawów.  
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I. SYMPTOMS  
 
he Latin name sklerosis multiplex means that the dis-
ease process occurs in many (multiplex) sites of the 
nervous system [1]. In places of myelin damage, scars 
or indurations are formed. This is a disease related  
to nerve cells (neurons), glial cells (oligodendrocytes), 
brain immune cells (microglia) in which the myelin sheath 
around the nerve cell protrusions is damaged, which im-
pairs proper transmission of impulses along the nerve 
Multiple sclerosis – symptoms, diagnostics, 
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pathways in the brain and spinal cord. A demyelination 
process  is created with simultaneous or secondary decay of 
axial and secondary fibers. This leads to the formation of 
demyelination centers called plaques. The term ‘multiple’ 
reflects the scattering of the pathological process over vari-
ous parts of the nervous system as well as the interval of 
changes over time. [1-6] 
In most cases, multiple sclerosis begins with an acute epi-
sode of neurological symptoms – called an isolated syn-
drome, followed by a phase with periods of improvement 
and worsening. MS can cause numerous symptoms [7]. The 
term of the isolated CIS syndrome is used to determine the 
first ever episode of neurological disorders suggesting CNS 
demyelination. The syndrome develops acutely or sub-
acutely and reaches maximum intensity in the period of 2-3 
weeks. Symptoms must last no less than 24 hours, without 
fever, infections and symptoms of encephalopathy. CIS is 
single-phase and usually monofocal. Typical clinical symp-
toms of CIS include: core syndrome, retrobulbar optic neu-
ritis, cerebral or cerebellar brain damage syndrome and 
hemispheric syndrome. Retrobulbar neuritis usually in-
volves only one optic nerve. The involvement of both 
nerves allows to exclude MS and indicates a different pa-
thology. Symptoms of inflammation develop within a few 
hours, disappear after about 2 months. The degree of with-
drawal of inflammation symptoms depends on the size of 
the changes caused. The core syndrome in CIS is under-
stood as incomplete transverse myelitis. The most common 
symptom is sensory disturbance, patients complain of tin-
gling and numbness in the limbs. It can be said that these 
symptoms usually start in one place and move up, down 
and to the opposite side. The symptoms of the stem syn-
drome include cerebellar ataxia and nystagmus, while the 
symptom accompanying the damage of the trunk is double 
vision. [1,8,9] 
The disease manifests itself in a different way for differ-
ent people. For some, it occurs in the form of repetitive 
relapses to a lesser or greater extent. The course of the dis-
ease is difficult to determine at the beginning of the dis-
ease. Some may have one or two attacks, after which the 
disease may be asymptomatic or with mild symptoms 
throughout life. Unfortunately, in many cases sooner or 
later the disease will manifest itself in the form of repetitive 
and increasing relapses. The disease is most often multi-
phasic and the course is accompanied by periods of exacer-
bation and remission, which is why the disease is referred 
to as a remission disease [1,10]. Depending on the place of 
the process destroying myelin, various symptoms appear. 
Multiple sclerosis affects the occurrence of many symp-
toms. They can be unexpected and sudden, or develop 
gradually and slowly [11]. The most common symptoms 
are movement disorders, muscle weakness and muscle 
spasms. Post-traumatic motion disorders are characterized 
by paresis or more frequent spastic paralysis occurring in 
more than half of the patients. Spastic paralysis is the result 
of damage to the upper motor neuron and is manifested by 
an increase in muscle tension and an increased response to 
stretching. Spasticity in MS assumes different patterns, 
depending on the location and number of demyelination 
lesions. The most common form of paralysis is spasticity 
associated with the flexion or extension of the knee joint of 
a significant degree and increased tension of the muscles 
that bring the hip joint, and sometimes an excessive exten-
sion in the ankle joints in the form of clubfoot. In the case 
of multiple sclerosis a characteristic symptom of a penknife 
appears, which is characterized by a growing tension dur-
ing the stretching of the muscle. Spasticity significantly 
impairs the patient's life, causes pain and limits the ability 
to perform everyday movement. The person walks on a 
wide support, and in the later period of the disease a systol-
ic-atactic gait is evident. Patients often struggle with mobil-
ity, coordination and balance. 
In addition, the disease is accompanied by visual disturb-
ances that may be manifested by ophthalmological inflam-
mation of the cranial nerve II or a problem with eye move-
ment. Retrobulbar optic neuritis is usually the first symp-
tom of multiple sclerosis. Inflammation is manifested by 
inadequate visual acuity, which in turn can lead to blind-
ness. Long-term tiredness is also an inherent symptom. 
There may occur nystagmus, scanning speech, dysmetria, 
as well as intricate tremor with injuries to the cerebellum. 
Tremor occurs during any movement and increases at the 
end of movement. The manifestation of MS are also prob-
lems with swallowing called dysphagia. Cognitive disor-
ders of various degrees and symptoms of depression are 
also frequent. It is not uncommon for sphincter disorders 
such as urinary incontinence, urgency, urinary retention and 
constipation. More than a half of people can notice overac-
tive bladder detrusor muscle. This contributes to urinary 
incontinence leading to disturbed micturition. Bladder in-
fection may develop as a result of its improper functioning. 
If the patient's condition deteriorates, progressive impair-
ment of the lower urinary tract occurs. Faecal incontinence 
is much less common, and such disorder is more likely to 
occur in a form of constipation. In addition, people who are 
ill often have sexual problems that occur for men in the 
form of impotence, and for women, there is frigidity and 
menstrual disorders. A well-known symptom is the feeling 
of ‘current’ running along the spine, the Lhermitte symp-
tom, although it is not a pathognomonic symptom for MS. 





After the head flexion, the patient feels a current that goes 
along the spine or from the neck towards the upper and 
lower limbs. Neuropathic pain is the most common type of 
pain in MS that causes suffering. It is described as perma-
nent, troublesome, stinging or as an intense tingling. It most 
often occurs in the lower limbs. [1,5,7,10-13] 
The disease also includes sensory disorders, which include 
hypoesthesia, hypersensitivity and paraesthesia. Paresthesia 
occurs in a form of tingling, scalding, burning pain and a 
feeling of pressure on the surface of the skin with increased 
sensitivity. Pain associated with paresthesia can be crush-
ing, stinging, pulsing and tightening. Sometimes patients 
have the inability to recognize objects by means of gripping 
them while maintaining the sense of touch, movement and 
position. Patients often complain of acute pain in the limbs 
and in torso area. In addition to severe pains, there are par-
oxysmal tonic spasms in the limbs. Cognitive dysfunction 
occurs in nearly half of the affected patients. Problems with 
attention, memory, pace of information processing and 
visuospatial perception are visible. Some people suffer 
from mental disorders during the illness. Patients suffer 
from emotional disorders, they can quickly transition from 
depression to euphoria, which sometimes is inappropriate 
for a given situation. Dementia, hysterical states, and some-
times hypochondrial states are also noted [1,3,5,12]. 
Multiple sclerosis is a well-known and widespread dis-
ease that contributes significantly to disability. It is charac-
terized by the changing nature of the course and difficulty 
in making further diagnosis [1]. The first direct meeting of 
a person with multiple sclerosis takes place before the final 
diagnosis at the time of the suspicion of the disease. The 
difficult period in the life of the patient and his family be-
gins when the first disturbing symptoms appear. The varie-
ty of these symptoms and the severity of MS affect the 
quality of life in its various areas [2.5]. The quality of life 
is closely related to the health of the patient and his physi-
cal, mental and social status. Patients with multiple sclero-
sis every day have to deal with numerous problems related 
to the movement, but also to the mental and social sphere, 
which has a significant impact on their quality of life. There 
is no doubt that MS belongs to diseases that have a nega-
tive impact on human existence, causing, above all, a limi-
tation of individual physical and social activity. Tiredness 
is a common feature of people with multiple sclerosis. 
Tiredness does not come from exercise, but it is more relat-
ed to exhaustion caused by small progresses, minor im-
provements after rest or a sense of general weakness [14]. 
Tiredness is an objective feeling of lack of energy to start 
any physical activity [15]. Tiredness can be primary or sec-
ondary. Uncertainty is one common feature of a difficult 
and unpredictable illness, which is why it is necessary to 
physically adapt a given person to the existing limitations, 





In order to implement the treatment of multiple sclerosis 
as quickly as possible, the patient should be accurately and 
quickly diagnosed. Early diagnosis may affect the prolon-
gation of the period which is characterized by a reduced 
number of symptoms. Currently, there is no specific diag-
nostic test that would 100% indicate multiple sclerosis [1]. 
In order to diagnose symptoms, a basic examination is car-
ried out, which includes the interview and neurological 
examination, as well as additional tests. Biochemical tests 
are also important, those include blood counts, ESR, uri-
nalysis, liver and kidney functioning, the presence of anti-
nuclear antibodies. 
The doctor who diagnoses a patient is supported tests such 
as magnetic resonance and cerebrospinal fluid examination, 
which are helpful in diagnosing multiple sclerosis. There is 
no generally available and existing set of tests to be per-
formed for patients with a suspicion of MS. The doctor 
decides about the right choice, guided by the symptoms and 
complaints of the patient. Laboratory tests are carried out in 
order to exclude the possibility of other diseases whose 
clinical picture resembles MS [1,3,12,16,17] 
A very sensitive and basic diagnostic method is magnetic 
resonance imaging [1]. The majority of patients with clini-
cally defined MS have visible changes in the brain MR [18-
23]. 
In the process of determining the final diagnosis, an im-
portant examination is also magnetic resonance of the spi-
nal cord. It is a necessary examination in the case of prima-
ry progressive MS and in the presence of spinal symptoms. 
In addition to the progressively occurring focal lesions, one 
of the important features of the magnetic resonance imag-
ing is brain and spinal atrophy. It occurs regardless of the 
stage and clinical form. Magnetic resonance imaging is not 
only a diagnosis, it is also helpful when monitoring and 
controlling the progressions of the disease.[18-23]. 
The examination of cerebrospinal fluid is also useful in 
diagnosis. This test is appropriate in uncertain situations, 
for example for patients with atypical or only subjective 
clinical symptoms or with the coexistence of other autoim-
mune diseases. [13,24] Although medicine has more and 
more modern diagnostic methods, there are still difficulties 
in establishing diagnosis of MS [1]. 
 







Prognosis of the disease and its clinical activity is based  
mainly on the assessment of clinical parameters and mag-
netic resonance imaging. The course of multiple sclerosis is 
variable and difficult to predict [1]. It is believed that 
women have better prognosis than men, especially if the 
disease started after the age of 40. Life expectancy is not 
much shorter than among the general population. The main 
problem, therefore, is not quicker mortality, but problems 
that a person encounters during their life, such as its re-
duced quality and progressive disability [10]. Negative 
prognostic factors include: a large conversion factor of 
relapses in the period of first 5 years of disease duration, 
uncertain withdrawal of emerging symptoms after the first 
relapses, a short time between the first and second relapse 
and progressive disability along with cognitive impairment 
at the beginning of the disease. Progressing limited physi-
cal fitness leads to limitations in the distance of walking, 
and after a longer period to the need to use one-sided sup-
port [1,2,10]. Factors that have a positive impact on the 
prognosis of multiple sclerosis are: young age of diagnosis, 
the initial appearance of sensory symptoms or optic neuri-
tis, rapid withdrawal of symptoms after the relapses and 
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